ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Advancements in molecular diagnostic techniques and automation technologies are revolutionizing the field of antimicrobial susceptibility testing. Traditional AST methods based on culture and phenotypic identification are being replaced by rapid diagnostic tests that detect genetic markers of drug resistance directly from clinical samples. Technologies, such as polymerase chain reaction (PCR), DNA microarrays, mass spectrometry, and whole genome sequencing, are enabling the detection of resistance within hours instead of days. At the same time, fully automated systems for AST are reducing turnaround time and labor, improving efficiency as well as standardization of test results. This shift from conventional methods to innovative diagnostic platforms is propelling the antimicrobial susceptibility testing market growth. Diagnostic companies are continuously launching simple, user-friendly systems suitable for routine testing in core laboratories as well as point-of-care testing. The development of platforms that integrate sample-to-result workflow and provide results comparable to reference methods is enhancing the AST uptake significantly. Thus, technological evolution is a key driver as it addresses some of the limitations of existing methods improving antibiotic stewardship.